As of 2025-08-04, the Relative Valuation of Citius Pharmaceuticals Inc (CTXR) is (54.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Citius Pharmaceuticals Inc based on Relative Valuation is -4324.8%.
The range of the Relative Valuation is (52.09) - (53.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 16.8x - 18.3x | 17.4x |
Forward P/E multiples | 17.9x - 22.8x | 20.2x |
Fair Price | (52.09) - (53.25) | (54.50) |
Upside | -4137.8% - -4227.9% | -4324.8% |
Date | P/E |
2025-08-01 | -0.44 |
2025-07-31 | -0.47 |
2025-07-30 | -0.48 |
2025-07-29 | -0.51 |
2025-07-28 | -0.53 |
2025-07-25 | -0.57 |
2025-07-24 | -0.58 |
2025-07-23 | -0.57 |
2025-07-22 | -0.50 |
2025-07-21 | -0.50 |
2025-07-18 | -0.53 |
2025-07-17 | -0.55 |
2025-07-16 | -0.51 |
2025-07-15 | -0.56 |
2025-07-14 | -0.57 |
2025-07-11 | -0.54 |
2025-07-10 | -0.56 |
2025-07-09 | -0.61 |
2025-07-08 | -0.67 |
2025-07-07 | -0.72 |
2025-07-03 | -0.76 |
2025-07-02 | -0.72 |
2025-07-01 | -0.65 |
2025-06-30 | -0.55 |
2025-06-27 | -0.53 |
2025-06-26 | -0.46 |
2025-06-25 | -0.41 |
2025-06-24 | -0.44 |
2025-06-23 | -0.35 |
2025-06-20 | -0.37 |
2025-06-18 | -0.31 |
2025-06-17 | -0.29 |
2025-06-16 | -0.27 |
2025-06-13 | -0.30 |
2025-06-12 | -0.32 |
2025-06-11 | -0.35 |
2025-06-10 | -0.36 |
2025-06-09 | -0.47 |
2025-06-06 | -0.29 |
2025-06-05 | -0.29 |
2025-06-04 | -0.30 |
2025-06-03 | -0.30 |
2025-06-02 | -0.26 |
2025-05-30 | -0.23 |
2025-05-29 | -0.24 |
2025-05-28 | -0.24 |
2025-05-27 | -0.24 |
2025-05-23 | -0.24 |
2025-05-22 | -0.25 |
2025-05-21 | -0.23 |